Unlike alarming evidence suggesting an increased risk of death with the use of paclitaxel-coated balloons and stents in the peripheral, a meta-analysis of 26 randomized controlled trials and 4,590 patients finds no increased risk of mortality when drug-coated balloons (DCBs) were used in coronary arteries.